Contact this trialFirst, we need to learn more about you.
Tyrosine Kinase Inhibitor
Pazopanib for Advanced or Refractory Cancer
Recruiting1 awardPhase 1
Jacksonville, Florida
This trial is studying the side effects and best dose of pazopanib hydrochloride for treating patients with solid tumors that have spread or are resistant to treatment. Samples of blood from patients will be studied to learn more about how the drug affects the body and how well patients respond to treatment.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service